Skip to main content
. Author manuscript; available in PMC: 2009 Jul 9.
Published in final edited form as: Reprod Sci. 2009 Mar 24;16(6):596–604. doi: 10.1177/1933719109332820

Fig. 7.

Fig. 7

Effect of cyclic guanosine monophosphate (cGMP) inhibition via 1H-[1,2,4]oxadiazolo[4,3-α-]quinoxalin-1-one (ODQ) on venous smooth muscle response to DETA/NO in nonpregnant (NP, n = 6) and late pregnant animals (LP, n = 6). Solid bars denote response in the absence of ODQ, and open bars show response after administration of a maximal concentration of ODQ (10 mmol/L). Although there was a significant (P < .05) decrease in dilation in both groups in the presence of ODQ, the extent of residual dilation was similar (P > .05).